DrugPatentWatch

Competitive intelligence on small-molecule drugs and the 80,000 patents covering them

Simple flat-rate subscription plans

Ultimate Plan

$495/ month or  $2,495/ year

Tradename: NICODERM CQ

Summary for Tradename: NICODERM CQ

Patents:2
Applicants:1
NDAs:1
Suppliers: see list5
drug
patent expirations by year for
 NICODERM CQ

Clinical Trials for: NICODERM CQ

Pilot Pharmacokinetic Study of Investigational Sublingual Nicotine Tablet Versus COMMIT Nicotine Lozenge
Status: Recruiting Condition: Nicotine Pharmacokinetic Study

Single-dose Nicotine Pharmacokinetics With a New Oral Nicotine Replacement Product
Status: Completed Condition: Tobacco Dependence

Comparison of Pharmacokinetic Profiles of Two Nicotine Gum Formulations
Status: Completed Condition: Smoking Cessation

Neural Mechanisms Underlying Nicotine and Alcohol Combinations
Status: Recruiting Condition: Focus: Effects of Nicotine and Alcohol on Brain Circuits

Multiple-dose Nicotine Pharmacokinetics With a New Oral Nicotine Replacement Product.
Status: Completed Condition: Tobacco Dependence

Nicotine Vaccination and Nicotinic Receptor Occupancy
Status: Completed Condition: Nicotine Dependence

Nicotine Dependence, Withdrawal and Replacement Therapy Assessed by PET Imaging
Status: Recruiting Condition: Nicotine Dependence

Bioequivalence Between an Oral Nicotine Replacement Product and NicoretteĀ® Gum
Status: Completed Condition: Tobacco Dependence

Nicotine Lozenge Bioequivalence Study
Status: Completed Condition: Smoking Cessation

Reduced Nicotine Content Cigarettes in Smokers of Lower Socioeconomic Status
Status: Not yet recruiting Condition: Tobacco Dependence

Courtesy of ClinicalTrials.org
See more clinical trials for this drug
Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sanofi Aventis Us
NICODERM CQ
nicotine
FILM, EXTENDED RELEASE;TRANSDERMAL020165Aug 2, 1996OTCYes8,075,911<disabled>Y<disabled>
Sanofi Aventis Us
NICODERM CQ
nicotine
FILM, EXTENDED RELEASE;TRANSDERMAL020165Aug 2, 1996OTCYes8,663,680<disabled>Y<disabled>
This preview shows a limited data set
Complete access is available with a Subscription
first patents previous patents next patents last patents

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for: NICODERM CQ

Drugname Dosage Strength RLD Submissiondate
nicotineTransdermal System7 mg/24 hrs, 14 mg/24 hrs, and 21 mg/24 hrsNicoderm CQ5/30/2014

« Back to Dashboard

DrugPatentWatch Archives

You are viewing the current data set
Select a link below to view the archives:

 2000  2001  2002  2003  2004  2005  2006  2007  2008  2009 
 2010  2011  2012  2013 

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Connect with Social Media:

Follow DrugPatentWatch on Twitter Connect with DrugPatentWatch on Linkedin Drug Patents on LinkedIn

Copyright © 2002-2014 thinkBiotech LLC. ISSN: 2162-2639

Other thinkBiotech sites: BiotechUBiotechBlogJournal of Commercial Biotechnology

`abc